×
About 1,156 results

ALLMedicine™ Hepatitis D Center

Research & Reviews  549 results

Clinical effects of NTCP-inhibitor myrcludex B.
https://doi.org/10.1111/jvh.13490
Journal of Viral Hepatitis; Cheng D, Han B et. al.

Feb 18th, 2021 - With extensive research on the pathogenesis and treatment of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections, the current treatment of interferon and nucleoside or nucleotide analogues provides reasonable control of viral replicatio...

The changing scenario of hepatitis D.
https://doi.org/10.1016/j.jhep.2021.01.014
Journal of Hepatology; Rizzetto M, Hamid S et. al.

Jan 23rd, 2021 - The global scenario of hepatitis D is changing with the widespread implementation of vaccination against hepatitis B. In high-income countries that achieved optimal control of HBV, the epidemiology of hepatitis D is dual, consisting of an ageing c...

Effectiveness of pegylated interferon monotherapy in the treatment of chronic hepatitis...
https://doi.org/10.1016/j.antiviral.2020.104995
Antiviral Research; Abdrakhman A, Ashimkhanova A et. al.

Dec 15th, 2020 - Chronic HDV infection often is associated with aggressive form of liver disease, compared to chronic HBV mono-infection. However, chronic HDV treatment is challenging because currently there is no approved regimen for affected patients. While stan...

New insights into HDV persistence: The role of interferon response and implications for...
https://doi.org/10.1016/j.jhep.2020.11.032
Journal of Hepatology; Zhang Z, Urban S

Dec 4th, 2020 - Chronic hepatitis D (CHD), a global health problem, manifests as the most severe form of viral hepatitis. The causative agent, HDV, is the smallest known human virus; it replicates its circular single-stranded RNA genome in the nucleus of hepatocy...

see more →

Clinicaltrials.gov  579 results

Clinical effects of NTCP-inhibitor myrcludex B.
https://doi.org/10.1111/jvh.13490
Journal of Viral Hepatitis; Cheng D, Han B et. al.

Feb 18th, 2021 - With extensive research on the pathogenesis and treatment of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections, the current treatment of interferon and nucleoside or nucleotide analogues provides reasonable control of viral replicatio...

The changing scenario of hepatitis D.
https://doi.org/10.1016/j.jhep.2021.01.014
Journal of Hepatology; Rizzetto M, Hamid S et. al.

Jan 23rd, 2021 - The global scenario of hepatitis D is changing with the widespread implementation of vaccination against hepatitis B. In high-income countries that achieved optimal control of HBV, the epidemiology of hepatitis D is dual, consisting of an ageing c...

Effectiveness of pegylated interferon monotherapy in the treatment of chronic hepatitis...
https://doi.org/10.1016/j.antiviral.2020.104995
Antiviral Research; Abdrakhman A, Ashimkhanova A et. al.

Dec 15th, 2020 - Chronic HDV infection often is associated with aggressive form of liver disease, compared to chronic HBV mono-infection. However, chronic HDV treatment is challenging because currently there is no approved regimen for affected patients. While stan...

New insights into HDV persistence: The role of interferon response and implications for...
https://doi.org/10.1016/j.jhep.2020.11.032
Journal of Hepatology; Zhang Z, Urban S

Dec 4th, 2020 - Chronic hepatitis D (CHD), a global health problem, manifests as the most severe form of viral hepatitis. The causative agent, HDV, is the smallest known human virus; it replicates its circular single-stranded RNA genome in the nucleus of hepatocy...

see more →

News  27 results

Risk Factors Can Help Spot People Who Need Hep D Screening
https://www.medscape.com/viewarticle/940855

Nov 12th, 2020 - NEW YORK (Reuters Health) - Several risk factors associated with hepatitis D virus (HDV) infection can be used to identify people who should be screened, researchers report. "It was interesting to find that the risk factors that were identified in...

Hepatitis D Virus Coinfection Boosts HBV Healthcare Costs
https://www.medscape.com/viewarticle/922853

Dec 19th, 2019 - NEW YORK (Reuters Health) - Hepatitis delta virus (HDV) infection, which occurs only as a co-infection with acute hepatitis B (HBV) or a superinfection with chronic HBV, is associated with higher healthcare utilization and costs than HBV alone, a ...

HDV combo therapy reduces viral loads
https://www.mdedge.com/gihepnews/article/211868/hepatology/hdv-combo-therapy-reduces-viral-loads?channel=346
Will Pass, MDedge News

Nov 8th, 2019 - BOSTON – For most patients with chronic hepatitis D virus (HDV) infection, combination therapy with lonafarnib, ritonavir, and peginterferon may significantly decrease viral loads, based on interim results from the phase IIa LIFT trial. After 6 mo.

Viral Hepatitis Overview: Osmosis Study Video
https://www.medscape.com/viewarticle/895006

Apr 19th, 2018 - What is the hepatitis virus? Well, the hepatitis virus invades liver cells and causes inflammation in the liver tissue. Five hepatitis viruses are recognized: hepatitis A, hepatitis B, hepatitis C, hepatitis D, and hepatitis E. They all have sligh...

In reply: Acute liver failure
https://www.mdedge.com/ccjm/article/110841/hepatology/reply-acute-liver-failure?channel=164
Tavankit Singh, MD, Nancy Gupta, MD et. al.

Aug 1st, 2016 - In Reply: We thank Dr. Homler for bringing hepatitis D as a potential cause of acute liver failure to our attention.

see more →

Patient Education  1 results see all →